Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Omcazio (cabozantinib laurylsulfate)FDA approves Omcazio (cabozantinib laurylsulfate)3 September 2026The FDA approved Omcazio (cabozantinib laurylsulfate), a drug from Handa Oncol. Form: Capsule, Oral. Application NDA220613.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)